IO Biotech, Inc. — Investor Relations & Filings
IO Biotech, Inc. is a clinical-stage biopharmaceutical company developing novel, immune-modulatory therapeutic cancer vaccines. The company's proprietary T-win technology platform is engineered to create dual-action vaccines that activate the patient's T cells to simultaneously target and eliminate both cancer cells and immune-suppressive cells within the tumor microenvironment. These off-the-shelf therapies are intended to improve outcomes for patients with various solid tumors. The lead product candidate, Cylembio® (IO102-IO103), is being evaluated in clinical trials for melanoma and other cancers, while additional pipeline candidates are in preclinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IO Biotech, Inc. (0001865494) (Filer) | 2026-03-31 | English | |
| 8-K Filing | 2026-02-13 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-02-06 | English | |
| 8-K Filing | 2026-01-30 | English | |
| Major Shareholding Notification 2026 | 2026-01-23 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 33114886 | 8-K - IO Biotech, Inc. (0001865494) (Filer) | 2026-03-31 | English | ||
| 32118566 | 8-K Filing | 2026-02-13 | English | ||
| 32118523 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32118548 | SCHEDULE 13G Filing | 2026-02-06 | English | ||
| 32118544 | 8-K Filing | 2026-01-30 | English | ||
| 13468661 | Major Shareholding Notification 2026 | 2026-01-23 | English | ||
| 13468663 | 8-K | 2026-01-21 | English | ||
|
2025
8 filings
| |||||
| 13468665 | 8-K | 2025-12-19 | English | ||
| 13468666 | 8-K | 2025-11-21 | English | ||
| 13468669 | 8-K | 2025-11-18 | English | ||
| 13468670 | Major Shareholding Notification 2025 | 2025-11-15 | English | ||
| 13468675 | 10-Q | 2025-11-14 | English | ||
| 13468676 | 8-K | 2025-11-14 | English | ||
| 13468677 | Major Shareholding Notification 2025 | 2025-11-05 | English | ||
| 13468679 | 8-K | 2025-09-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
IO Biotech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34883/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34883 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34883 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34883 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34883}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IO Biotech, Inc. (id: 34883)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.